RxDoctor Payments Data

Samantha Boren

Psychiatric/Mental Health · Corinth, MSNPI 1245910298

Payments from drug & device makers

$799in general payments, 2019–2025

Across 50 payments — averaging $15.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$256
  • AbbVie$174
  • E.r. Squibb & Sons, L.L.C.$81
  • Otsuka America Pharmaceutical, Inc.$70
  • Johnson & Johnson$65
  • Vanda Pharmaceuticals Inc.$55
  • plus $98 from 4 others

What the payments were for

  • Food & beverage$77297%
  • Education$273%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$799 in reported general payments places this provider in the 50th percentile of 486 psychiatric/mental health providers in Mississippi.

See all psychiatric/mental health providers in Mississippi

Medicare billing

Part B allowed, 2024
$3,344
Medicare patients
26
Services billed
57

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate26$78,110
Abilify MaintenaAripiprazole13$36,670
VraylarCariprazine Hcl12$19,997
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl22$2,007
Aripiprazole46$803
Duloxetine Hcl58$567
Bupropion XlBupropion Hcl33$473
Quetiapine Fumarate50$329
Hydroxyzine Pamoate43$308
Trazodone Hcl41$305
Lamotrigine15$304
Olanzapine24$261
Benztropine Mesylate13$181
Prazosin Hcl15$176
Buspirone Hcl28$175

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$65$78,11026 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$70$36,67013 claims
AbbVieVraylar$174$19,99712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 486 psychiatric/mental health providers in Mississippi.

Other psychiatric/mental health in Corinth

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →